“As we refine our understanding of how patients’ mutations affect larger biological networks, that’s going to improve doctors’ predictive power in a clinical setting.”
Nevan Krogan is a Senior Investigator at the Gladstone Institutes and a Professor of Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF). He is known for his systems biology approaches to bridging basic and clinical research and extracting mechanism and insight from large-scale biological datasets.
As the Director of UCSF’s Quantitative Bioscience Institute, Krogan studies the proteomics and genomics of cellular interactions related to infectious disease, neuropsychiatric disorders, and cancer. His research focuses on identifying how molecular networks respond to disease-causing mutations or infection by pathogens in order to general mechanistic insights and potential therapeutic targets.
Krogan has been recognized as one of Cell’s Top 40 Under 40 researchers, a Searle Scholar, and a Keck Young Distinguished Young Scholar.
Krogan earned his B.Sc. and M.Sc. from the University of Regina, where he pioneered the systematic affinity tagging, purification, and analysis of the majority of proteins in yeast. He received his Ph.D. in medical genetics from the University of Toronto.